DUBLIN--(BUSINESS WIRE)-- Research and
Markets(http://www.researchandmarkets.com/research/4f267f/canada_in_vitro_di)
has announced the addition of GlobalData 's new report
"Canada
In Vitro Diagnostics Market Outlook to 2017 - Clinical
Chemistry Genetic Testing, Haematology, Histology And
Cytology, Immuno Chemistry, Infectious Immunology and
Microbiology Culture" to their offering.

GlobalData's new report,
Canada In Vitro Diagnostics Market Outlook to 2017 - Clinical
Chemistry Genetic Testing, Haematology, Histology And
Cytology, Immuno Chemistry, Infectious Immunology and
Microbiology Culture provides key market data on the
Canada In Vitro Diagnostics market. The report provides value
(USD million) data for each segment and sub-segment within
seven market categories - Clinical Chemistry, Genetic
Testing, Haematology, Histology And Cytology, Immuno
Chemistry, Infectious Immunology and Microbiology Culture.
The report also provides company shares and distribution
shares data for each of the aforementioned market categories.
The report is supplemented with global corporate-level
profiles of the key market participants with information on
company financials and pipeline products, wherever available.

Scope

Market size and company share data for In Vitro
Diagnostics market categories - Clinical Chemistry, Genetic
Testing, Haematology, Histology And Cytology, Immuno
Chemistry, Infectious Immunology and Microbiology Culture.

Annualized market revenues (USD million) data for each of
the segments and sub-segments within seven market categories.
Data from 2003 to 2010, forecast forward for 7 years to 2017.

2010 company shares and distribution shares data for each
of the seven market categories.

Global corporate-level profiles of key companies
operating within the Canada In Vitro Diagnosticsmarket.

Companies Mentioned:

Siemens Healthcare

Abbott Laboratories

F. Hoffmann-La Roche Ltd.

Beckman Coulter, Inc.

Ortho-Clinical Diagnostics Inc.

bioMerieux S.A.

Becton, Dickinson and Company

Bio-Rad Laboratories, Inc.

Biomedica Diagnostics Inc.

Sysmex Corporation

Qiagen N.V.

Immucor, Inc.

Alere Inc.

Gen-Probe Incorporated

DiaSorin S.p.A

Thermo Fisher Scientific Inc.

Phadia AB

Hologic, Inc.

Grifols, S.A.

Life Technologies Corporation

HORIBA, Ltd.

PerkinElmer, Inc.

For more information visit
http://www.researchandmarkets.com/research/4f267f/canada_in_vitro_di

Read more:
Research and Markets: Canada In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing ...